New in @TheLancetNeuro: first large scale characterization of proteomic changes in patients treated with lecanemab in a real world setting https://t.co/KuHIdvKXCb.
Proteomic changes were analyzed in 197 lecanemab-treated patients followed over two years from the @WashUMedADRC